Thursday, July 13, 2023

New AMP testing recommendations for alleles in CYP3A4 and CYP3A5

›
The Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharma...
Wednesday, July 12, 2023

Insights on CYP2C19 and phenoconversion

›
Phenoconversion in the PGx context is a drug-drug interaction that impacts a drug metabolizing phenotype such that it mimics the effects of ...
Monday, June 26, 2023

ClinGen Pharmacogenomics Working Group (PGxWG) Survey To Close Soon

›
  The  ClinGen Pharmacogenomics Working Group (PGxWG) 's anonymous   survey will close soon after this Friday, June 30, 2023 . Our goal...
Friday, June 9, 2023

ClinPGx Sessions at PGRN 2023 Conference and ClinGen Summer Workshops

›
At the upcoming PGRN 2023 annual conference in Memphis, Dr. Teri E. Klein, the principle investigator for PharmGKB, ClinGen, CPIC and Pharm...

ClinGen Pharmacogenomics Working Group (PGxWG) Survey Open Until June 30, 2023

›
The  ClinGen Pharmacogenomics Working Group (PGxWG) 's anonymous   survey  is OPEN until June 30, 2023 . Our goal is to gather opinions ...
Wednesday, May 10, 2023

Announcement of PharmVar Content Changes

›
PharmVar continues to evolve and strive to offer high-quality content to our global users. To allow us to bring new clinically relevant con...
Monday, May 1, 2023

CYP3A5 genotyping is a more accurate predictor of drug response than race alone

›
  A new paper in Journal of Clinical Pharmacology from a group at Indiana University [PMID:37042314] implemented genotyping for CYP3A5 in a...